Loading
Life sciences · Journal article
BMC Cancer · September 18, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
An anti–programmed death-ligand 1 (PD-L1) antibody–functionalized, multi-component silica nanosystem (SNS) was constructed to integrate a nanosilver (Ag) core, doxorubicin (Dox), and a manganese dioxide (MnO 2 ) tumor-microenvironment–responsive shell, and its antitumor activity and mechanisms were evaluated in 4T1 triple-negative breast cancer (TNBC) models. SNS was synthesized and characterized by dynamic light scattering and transmission electron microscopy, and anti–PD-L1 was conjugated to the nanoparticle surface via EDC coupling. Without targeting-groups SNS (WTSNS) and single-component controls (Ag@SNS, Dox@SNS, and Mn@SNS) were prepared. In 4T1 cells, fluorescence microscopy assessed uptake and subcellular localization, CCK-8 evaluated in vitro cytotoxicity in 4T1 cells and L929 fibroblasts and generated IC50 values, comet assay examined DNA damage, and qPCR analyzed apoptosis-related transcripts. In 4T1 tumor-bearing mice, near-infrared imaging, tumor growth monitoring, histology, and body-weight recording assessed tumor accumulation, antitumor efficacy, and biosafety. SNS formed uniform spherical nanoparticles (~ 95 nm) with a zeta potential of ~ − 22 mV. PD-L1 targeting enhanced cellular internalization and tumor accumulation compared with WTSNS. CCK-8 assays showed concentration-dependent cytotoxicity, with IC50 values of 15.60 and 12.42 µg/mL for WTSNS and SNS in 4T1 cells and 22.52 and 22.04 µg/mL in L929 cells, respectively. SNS induced the strongest DNA damage, upregulated BAX, Caspase-3, Caspase-9, and downregulated BCL-2. In vivo, SNS achieved the greatest tumor growth suppression with stable body weight and no evident major-organ injury. Overall, anti–PD-L1-guided SNS supported synergistic TNBC therapy through DNA-damage-associated apoptosis.